We also performed tumor eradication and recurrence assay by implanting MDA‐MB‐231 NTC or ODC1/SRM knockdown subclone cells into SCID mice, treating the mice with paclitaxel when tumors became palpable, terminating treatment when tumors were fully eradicated, and monitoring tumor recurrence. This evidence concerns the gene ODC1 and neoplasm.